dotarem 0.5 mmol/ml inj. sol. i.v. pre-filled syr.
guerbet - gadoterate meglumine 0,5 mmol/ml - eq. gadoteric acid 279,32 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine 0.5 mmol/ml - gadoteric acid
dotarem 0.5 mmol/ml inj. sol. i.v. vial
guerbet - gadoterate meglumine 0,5 mmol/ml - eq. gadoteric acid 279,32 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine 0.5 mmol/ml - gadoteric acid
dotarem 0.5 mmol/ml inj. sol. i.v. vial
guerbet - gadoterate meglumine 0,5 mmol/ml - eq. gadoteric acid 279,32 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine 0.5 mmol/ml - gadoteric acid
dotarem 0.5 mmol/ml inj. sol. i.v. pre-filled syr.
guerbet - gadoterate meglumine 0,5 mmol/ml - eq. gadoteric acid 279,32 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine 0.5 mmol/ml - gadoteric acid
gadotersäure agfa 0,5 mmol/ml injektionslösung in durchstechflaschen
gadotersäure noridem 0,5 mmol/ml injektionslösung
dotarem solution
guerbet - gadoterate meglumine - solution - 376.9mg - gadoterate meglumine 376.9mg - other diagnostic agents
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid
clariscan 0.5 mmol/ml inj. sol. i.v. vial
ge healthcare a.s. - tetraxetan 202,46 mg/ml; gadolinium oxide 90,62 mg/ml; gadoterate meglumine - eq. gadoteric acid 279,3 mg/ml - solution for injection - 0,5 mmol/ml - gadoterate meglumine; tetraxetan 202.46 mg/ml; gadolinium oxide 90.62 mg/ml - gadoteric acid